MSD and Curon have announced that they have entered into a definitive agreement under which MSD has agreed to acquire CN201, a novel investigational clinical-stage bispecific antibody for the treatment of B-cell associated diseases.
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before.
Alcura, a provider of specialised clinical trial services and a part of Cencora, has been granted a Manufacturing and Importation Authorization (MIA) license for cell and gene therapies (CGT) by the Spanish Agency of Medicines and Medical Devices.
Packaging is a critical component of pharmaceuticals, protecting the integrity, safety, and efficacy of essential treatments throughout the supply chain and providing tools for product traceability. James Bury, director technology, Tjoapack explains.
Otsuka Pharmaceuticals is collaborating with Health Innovation Oxford HIN to evaluate the implementation and integration of a new digital therapeutic (DTx), CARE for MDD, intended to support the treatment of major depressive disorder (MDD).
Cresset, a provider of integrated in silico solutions for drug discovery announces the release of V9 - the latest version of its Flare platform for ligand-based and structure-based design, which includes a full integration of Spark.
The continued growth in demand for mini tablets (micro-tablets or mini-tabs) is hardly surprising given the benefits that they can deliver for healthcare professionals and their patients. Their
